Chronic hepatitis b Clinical Trials
Conditions / Chronic hepatitis b
Delta Trials catalogs 441 clinical trials for Chronic hepatitis b in its publicly accessible dataset. Within this set, 40 currently recruiting participants and 197 trials have reached completion. This research occurs across 838 participating sites around the world. An additional 204 trials are in other active phases such as not yet recruiting or pending status. Since 2020, 32 trials were withdrawn or terminated prior to completion. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations and statuses evolve over time.
Trial Status
441
Total Trials
40
Recruiting
197
Completed
204
Other Active
32
Terminated since 2020
838
Study Locations
Browse by location (838 total)
- Beijing, China 84 trialsAll trials in Beijing, China
- Seoul, South Korea 74 trialsAll trials in Seoul, South Korea
- Guangzhou, China 61 trialsAll trials in Guangzhou, China
- Shanghai, China 53 trialsAll trials in Shanghai, China
- Changchun, China 37 trialsAll trials in Changchun, China
- Taipei, Taiwan 37 trialsAll trials in Taipei, Taiwan
- Taipei, Taiwan 37 trialsAll trials in Taipei, Taiwan
- Auckland, New Zealand 37 trialsAll trials in Auckland, New Zealand
- Hong Kong, Hong Kong 36 trialsAll trials in Hong Kong, Hong Kong
- Chongqing, China 34 trialsAll trials in Chongqing, China
- San Francisco, United States 32 trialsAll trials in San Francisco, United States
- Nanjing, China 30 trialsAll trials in Nanjing, China
- Los Angeles, United States 29 trialsAll trials in Los Angeles, United States
- Hangzhou, China 29 trialsAll trials in Hangzhou, China
- Toronto, Canada 29 trialsAll trials in Toronto, Canada
- Kaohsiung City, Taiwan 26 trialsAll trials in Kaohsiung City, Taiwan
- New York, United States 26 trialsAll trials in New York, United States
- Wuhan, China 26 trialsAll trials in Wuhan, China
- Changsha, China 23 trialsAll trials in Changsha, China
- San Diego, United States 23 trialsAll trials in San Diego, United States